- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Brivaracetam – November 2017
Brivaracetam: Tablet 25 mg, Table 50 mg, Tablet 75 mg, Tablet 100 mg, Oral suspension 10 mg per mL
Last updated
2 March 2018